Harbin
Harbin
Harbin, Heilong Jiang, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations | Advanced Solid Tumors With MAPK Pathway Mutations | Recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT05886920 |